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 2 
Abstract 
 
 
Objective: Collagen accumulation and calcification are major determinants of atherosclerotic 
plaque stability. Extracellular vesicle (EV)-derived microcalcifications in the collagen-poor 
fibrous cap may promote plaque rupture. In this study, we hypothesize that the collagen 
receptor discoidin domain receptor-1 (DDR-1) regulates collagen deposition and release of 
calcifying EVs by vascular smooth muscle cells (vSMCs) through the TGF-β pathway.  
 
Approach and Results: VSMCs from the carotid arteries of DDR-1-/- mice and wild type 
littermates (n=5-10 per group) were cultured in normal or calcifying media. At days 14 and 21, 
vSMCs were harvested and EVs isolated for analysis. Compared to wild type, DDR-1-/- 
vSMCs exhibited a 4-fold increase in EV release (p<0.001) with concomitantly elevated 
alkaline phosphatase (ALP) activity (p<0.0001) as a hallmark of EV calcifying potential. The 
DDR-1-/- phenotype was characterized by increased mineralization (Alizarin Red S and 
Osteosense, p<0.001 and p=0.002, respectively) and amorphous collagen deposition 
(p<0.001). We further identified a novel link between DDR-1 and the TGF-β pathway 
previously implicated in both fibrotic and calcific responses. An increase in TGF-β1 release 
by DDR-1-/- vSMCs in calcifying media (p<0.001) stimulated p38 phosphorylation (p=0.02) 
and suppressed activation of Smad3. Inhibition of either TGF-β receptor-I or phospho-p38 
reversed the fibrocalcific DDR-1-/- phenotype, corroborating a causal relationship between 
DDR-1 and TGF-β in EV-mediated vascular calcification. 
 
Conclusion: DDR-1 interacts with the TGF-β pathway to restrict calcifying EV-mediated 
mineralization and fibrosis by vSMCs. We therefore establish a novel mechanism of cell-
matrix homeostasis in atherosclerotic plaque formation. 
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Nonstandard Abbreviations and Acronyms 
 
DDR-1 
WT 
DDR-1-/- 
LDL-R-/- 
 
discoidin domain receptor-1 
wild type 
discoidin domain receptor-1 knockout 
low-density lipoprotein receptor knockout 
vSMC vascular smooth muscle cell 
EV extracellular vesicle 
NM normal media 
β-GP β-Glycerophosphate 
NPP-1 ectonucleotide 
pyrophosphatase/phosphodiesterase-1 
ECM extracellular matrix 
TGF-β transforming growth factor β 
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Introduction 
 
 
Vascular calcification is a predictor of cardiovascular events and a major determinant of 
atherosclerotic plaque stability1. While macrocalcifications in the collagen-dense fibrous cap 
may promote structural stability of the plaque, microcalcifications in collagen-poor areas 
exert mechanical stress on the surrounding tissue, thus potentiating the risk of rupture and 
subsequent cardiovascular events2. Several determinants that further influence plaque 
stability have been identified, among which a high number and close spatial proximity of 
microcalcific deposits as well as a thin collagenous fibrous cap constitute the conditions most 
favorable for stress-induced rupture3. Emerging evidence suggests that vascular wall cells, 
including smooth muscle cells (vSMCs) and macrophages, release calcifying extracellular 
vesicles (EV) prone to aggregation in the extracellular matrix (ECM) and formation of calcific 
foci in the plaque4,5,6,29. However, the regulation of collagen production and calcifying EV 
release by vSMCs is incompletely understood. 
Discoidin domain receptors (DDR)-1 and 2 are a family of two receptor tyrosine kinases that 
exhibit substrate specificity for both fibrillar and non-fibrillar collagens7. DDR activity has 
been implicated in physiological processes such as cell migration8, differentiation9 and ECM 
remodeling10, whereas dysregulated DDR function has been linked to the progression of 
fibrosis, arthritis and cancer11. DDR-1, composed of five membrane-bound and two secreted 
isoforms generated by alternative splicing12, was found to play a complex role in the 
progression of atherosclerotic plaque formation13. By contrast, DDR-2 does not affect vSMC 
migration, proliferation or ECM remodeling in vitro14. Ahmad et al. found that DDR-1 
influences in vivo vascular calcification using DDR-1/LDL-receptor double knockout mice15. 
Recent findings on the role of DDR-1 in fibrocalcific response and the emerging influence of 
EVs in vascular calcification highlight a possible impact of DDR-1 on the fibrocalcific potential 
of vSMCs and their release of calcifying EVs. Despite extensive knowledge of the numerous 
pathways involved in DDR-1 downstream signaling12, a functional link between DDR-1 
signaling and its role in EV-mediated calcification as a predictor of atherosclerotic plaque 
stability remains to be elucidated. 
Transforming Growth Factor-β (TGF-β) and its signaling pathways are strongly associated 
with vSMC-mediated fibrosis16 and calcification17, suggesting a potential regulatory role in 
vSMC osteogenic differentiation and fibrocalcific response. A canonical pathway featuring 
the Smad proteins Smad2 and 3 and several non-canonical pathways comprising the 
MAPkinases Erk1/2, JNK and p38/MAPK are involved in TGF-β receptor activation. Both 
pathways are known to cross-talk with each other resulting in synergistic or antagonistic 
effects on potentially desirable biological outcomes18. In the context of atherosclerotic plaque 
progression, TGF-β1 promotes the osteogenic differentiation19 and calcifying potential20 of 
vSMCs in vitro and is abundantly expressed in calcified human atheromata21. The effect of 
TGF-β pathways on EV release and the fibro-calcific response in vSMCs, however, remains 
unclear. 
In this study, we hypothesize that DDR-1 signaling regulates EV-mediated vSMC fibrocalcific 
responses via TGF-β pathways. Wu et al. observed that DDR-1 depletion increases 
chondrogenic differentiation through enhanced expression of chondrogenic markers like 
SOX-9 and collagen II in human adipose-derived stem cells22. Moreover, the knockdown of 
DDR-1 in a tumor cell model reportedly stimulated the expression of TGF-β1 on the RNA and 
protein level23. Based on these findings, we demonstrate a functional crosstalk between 
DDR-1 and the TGF-β pathways involving Smad3 and p38 to regulate the release of 
calcifying EVs by vSMCs. This study introduces a novel mechanism balancing vascular 
fibrocalcific response in atherosclerotic plaque formation. 
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Materials and Methods 
 
 
Materials and Methods are available in the online-only Data Supplement. 
 
 
Results 
 
 
DDR-1 Deficiency Increases the Release of Calcifying EVs in vSMCs 
 
Nanoparticle Tracking Analysis (NTA) of collagenase-digested, purified supernatant from 
vSMCs after 14 and 21 days of culture showed a uniform size distribution with a mean 
particle size of 180-200±100nm throughout all samples and time points (Fig.1A). These 
findings are consistent with previous data on EV size distribution24. Compared to wild type 
littermates, DDR-1-/- vSMCs exhibited a significant increase in the release of EVs by 3.5-fold 
in normal media (p=0.0004) and 4-fold in calcifying media (p=0.003) at day 14 and a 2.5-fold 
increase in both media at day 21 (p<0.001; Fig.1B). Transmission electron microscopic 
(TEM) imaging of vSMCs after 21 days of culture displayed dense clusters of DDR-1-/- 
vSMCs surrounded by abundant ECM, whereas wild type cells showed sparse cell growth 
and little ECM production (Fig.1C). TEM images demonstrated an increased number of 
membrane-bound vesicular bodies in proximity with DDR-1-/- compared to wild type vSMCs. 
The particles displayed via TEM were found to match the EV size distribution observed using 
NTA (Supp.Fig.IB), confirming our finding of elevated EV release by DDR-1-/- vSMCs. Further 
analysis of the calcifying potential of isolated EVs revealed an increase in ALP activity in EVs 
from DDR-1-/- compared to wild type vSMCs by one order of magnitude in both normal and 
calcifying media after 14 days (p<0.0001) and 21 days (p<0.01, Fig.1D). The presence of β-
Glycerophosphate in calcifying media, mimicking osteogenic conditions, further induced EV 
release and ALP activity in EVs from wild type (46.1±23.0 vs. 107.5±7.4ng/well/mg protein, 
p<0.05; Supp.Fig.V) and DDR-1-/- vSMCs (581.3±68.3 vs. 878.2±155.4ng/well/mg protein, 
p<0.05) significantly, thus augmenting their calcifying potential. 
 
DDR-1-/- vSMCs Propagate Calcification Through the Expression of a Pro-Calcific Phenotype 
 
Consistent with elevated EV calcification potential, DDR-1-/- vSMCs exhibited increased ALP 
activity compared to wild type vSMCs as shown by a colorimetric staining assay after 14 and 
21 days of culture (Fig.2A). An ALP activity assay performed on cell lysates concordantly 
showed a significant increase in the presence of cytoplasmic and cell membrane-bound ALP 
in DDR-1-/- vSMCs in both normal and calcifying media at both days 14 (p=0.0003) and 21 
(p<0.01, Fig.2B). The addition of β-Glycerophosphate in calcifying media resulted in a linear 
increase in ALP activity over the 21 days of vSMC culture similar to that observed in EVs, 
suggesting a direct relationship between ALP expression in vSMCs and EV calcifying 
potential. Gene expression at 14 days of culture showed a concordant 6- and 9-fold 
upregulation of ALP mRNA in normal and calcifying media, respectively (p<0.01, Fig.2E). 
Further analysis of osteogenic differentiation in DDR-1-/- vSMCs revealed a 56.1±38.5-fold 
increase in the synthetic marker osteopontin, along with a 6.6±4.3-fold increase in the 
osteogenic marker Msx2 (p<0.01), whereas no significant difference compared to wild type 
was observed in related markers vimentin and Runx2 (Supp.Fig.VI). 
Compared to wild type, DDR-1-/- vSMCs exhibited increased Alizarin Red S-positive mineral 
deposition. Mineralization of DDR-1-/- cultures in calcifying media visibly progressed from 
days 14 to 21 with a more than 30-fold increase in Alizarin Red S absorbance compared to 
wild type at day 21 (p=0.0005, Fig.2C, 2D).  
Calcific deposition in the ECM is regulated by a balance of inorganic phosphate and 
pyrophosphate, which is dependent on ALP and its antagonist NPP-1 (Supp.Fig.IA)25. ALP 
produces phosphate for calcium phosphate complexation, whereas NPP-1 generates 
pyrophosphate, an inhibitor of mineralization. In DDR-1-/- vSMCs, the increase in ALP activity 
 6 
in EVs and ALP expression in vSMCs was accompanied by a concomitant increase in NPP-1 
activity in EVs in calcifying media (Supp.Fig.IB) and in cell lysates in both media 
(Supp.Fig.IC).  
 
DDR-1 Regulates EV-induced Fibrocalcific Response in vSMCs Through TGF-β1 
downstream signaling pathways 
 
Members of the TGF-β family modulate vascular fibrosis and calcification18. In calcifying 
media, DDR-1-/- vSMCs release elevated levels of TGF-β1 compared to wild type after 21 
days of culture (Fig.3A). TGF-β1 gene expression is doubled relative to wild type in DDR-1-/- 
vSMCs in both media at day 14 (Fig.3B). Western Blot analysis of TGF-β canonical and non-
canonical pathways after 21 days of culture unveiled a near complete suppression of Smad3 
phosphorylation (p<0.0001, Fig.3C) and a significant decrease in phosphorylated JNK 
(Supp.Fig.IVB) in DDR-1-/- vSMCs, whereas phosphorylation of p38 was increased 
significantly (p=0.02, Fig.3D). The inverse regulation of canonical and non-canonical TGF-β 
pathways in DDR-1-/- vSMCs observed in vitro was assessed in vivo through quantitative 
immunofluorescence of LDL-R-/- and DDR-1-/- LDL-R-/- aortic sections. The data show a 
significant increase in phospho-p38 (p=0.03) and a trending suppression of phospho-Smad3 
in the double knockout (p=0.06, Supp.Fig.VIII). No difference between wild type and DDR-1-/- 
vSMCs was observed in the levels of phospho-Erk1/2 (not shown), Smad2 (Supp.Fig.IVC) 
and Smad1/5 (Supp.Fig.IVD). The addition of the selective TGF-β receptor-I inhibitor 
SB431542 abrogated the changes in TGF-β1 release (p<0.0001, Supp.Fig.IVA) and TGF-β 
pathways observed in DDR-1-/- vSMCs, resulting in a complete suppression of Smad3 
phosphorylation in wild type and p38 phosphorylation in DDR-1-/- vSMCs (p<0.0001 and 
p=0.02, respectively; Fig.3D). These in vitro and in vivo findings support our hypothesis on a 
relationship between DDR-1 and TGF-β downstream signaling with manifold implications in 
vascular calcification.  
 
Inhibition of TGF-β Receptor Type I and p38 Mitigate the Osteogenic Potential of the DDR-1-
/- Phenotype 
 
The influence of DDR-1 on p38 and Smad3 phosphorylation as well as on TGF-β1 release by 
vSMCs raises the question whether these pathways contribute to the osteogenic phenotype 
exhibited by DDR-1-/- vSMCs and their release of calcifying EVs. After 21 days of culture in 
calcifying media, the addition of specific TGF-β receptor-I inhibitor SB431542 abrogated the 
previously observed 30-fold increase in calcific mineral deposition by DDR-1-/- vSMCs 
(p<0.0001, Fig.4A, 4B). Moreover, SB431542 treatment reduced EV release by DDR-1-/- 
vSMCs (p<0.0001, Fig.4C) and mitigated EV calcification potential demonstrated by a 
decrease in ALP activity (p<0.01, Fig.4D). Similarly, SB203580, a selective inhibitor of 
phospho-p38 MAPkinase downstream signaling, significantly suppressed EV release in 
DDR-1-/- vSMCs in normal (p<0.0001) and calcifying media (p<0.0001, Fig.4C) along with a 
significant decrease in EV ALP activity in normal (p<0.001) and calcifying media (p<0.0001, 
Fig. 4D). Thus, inhibition of TGF-β signaling by either SB431542 or SB203580 has an equal 
impact on major calcification endpoints including EV release and EV calcifying potential 
(p<0.0001, Fig.4A, 4B). In DDR-1-/- vSMCs, SB431542 and SB203580 consistently 
attenuated the activity of cytoplasmic and membrane-bound ALP (p<0.05) and NPP-1 
(p<0.01) after 14 days (Supp.Fig. IIIA+B).  
 
DDR-1 Exerts a Negative Feedback on Quantitative Collagen Synthesis in Response to 
Extracellular Collagen 
 
DDR-1 acts as a sensor for type I collagen in vSMCs, activating a negative feedback loop on 
collagen synthesis in human vSMCs10. In DDR-1-/- vSMCs, lack of collagen feedback from 
fibrillar collagen in the ECM not only resulted in increased collagen production (p<0.001, 
Fig.5B), but also led to defined changes in the three-dimensional structure of collagen fibers. 
The fluorescently labeled collagen binding protein CNA3526 detected a dense network of 
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amorphous collagen fibers devoid of spatial organization in cultures of DDR-1-/- vSMCs after 
21 days, whereas collagen produced by wild type vSMCs was found to be less dense 
(p<0.001), more fibrillar and restricted to the immediate vicinity of the vSMCs (Fig.5A). The 
addition of β-Glycerophosphate in calcifying media increased calcification in DDR-/- vSMCs 
compared to wild type as detected by a fluorescent calcium tracer27 (p=0.002). Addition of 
SB431542 reduced collagen synthesis (p<0.01) and calcific deposition in calcifying media 
(p<0.01) in DDR-1-/- vSMCs. Thus, TGF-β receptor inhibition re-established wild type 
conditions in DDR-1-/- vSMCs (Fig.5A, 5B).  
 
DDR-1 Deficiency Triggers TGF-β-mediated Calcific EV Release and Fibrotic Response in 
vivo 
 
Based on present findings demonstrating a fibrocalcific phenotype of DDR-1-/- vSMCs 
through an interaction with TGFβ signaling in vitro, we investigated the interactions between 
vSMCs, DDR-1, TGF-β1 and atherosclerotic plaque formation in vivo. The aortic arches of 
LDL-receptor knockout (LDL-R-/-) and DDR-1-/- LDL-R-/- mice on a 24-week high fat diet were 
analyzed for presence and distribution of calcific EVs, collagen and TGF-β1 expression. 
Picrosirius Red (PSR) staining revealed the spatial arrangement and packing density of 
collagen fibers under polarized light by enhancing natural birefringence. While green colors 
indicate thin, poorly-packed collagen, increased thickness and packing density causes a shift 
in birefringence to the reddish-orange spectrum28. DDR-1-/- LDL-R-/- aortic arches exhibited a 
network of thick, densely packed collagen fibers that were nearly undetectable in LDL-R-/- 
tissue sections (Fig.5C). For quantitative analysis, PSR-stained collagen was categorized 
into thin and loose (green), medium-sized (yellow) and thick, densely packed fibers (orange-
red). Mature, medium-sized fibers were expressed constitutively in the vessel wall of both 
groups regardless of fibrotic response (p=0.89, not shown) and were therefore excluded from 
analysis. Quantification of thin fibers (green) relative to thick bundles (red-orange) revealed a 
shift towards thick, densely packed collagen (45.53±19.78% vs. 54.47±19.78% thin fibers, 
p=0.01) in DDR-1-/- LDL-R-/-, whereas in LDL-R-/-, thin fibers were found to be more abundant 
(81.90 vs. 18.10±9.60% thick fibers, Fig.5D). 
Consistent with in vitro findings, immunohistochemistry for TGF-β1 detected positive areas in 
sections from DDR-1-/- LDL-R-/- mice in proximity to areas positive for thick, densely packed 
collagen. In LDL-R-/- aortic sections, however, TGF-β1 staining was scarce and rarely found 
in the vascular interstitium (Fig.5C), supporting our in vitro hypothesis on a functional 
connection between DDR-1 and the TGF-β pathway in the regulation of ECM homeostasis. 
Similarly, staining for ALP in DDR-1-/- LDL-R-/- sections showed signal in proximity to areas of 
plaque formation, whereas in the LDL-R-/- control, ALP expression was barely detectable 
(Supp.Fig.IX). 
Analysis of calcific EVs and EV aggregates using density-dependent color scanning electron 
microscopy (DDC-SEM), a novel method identifying early stages of calcification in the form of 
calcifying vesicular structures29, showed a multitude of isolated and aggregating vesicular 
particles of equal density as adjacent calcific deposits in plaque areas from DDR-1-/- LDL-R-/- 
mice, bearing strong morphological resemblance to calcifications found in human atheromata 
(Fig.5E). By contrast, plaques from LDL-R-/- mice presented as mostly fibrotic with only few 
vesicular structures and calcific deposits of nodular appearance, revealing a pattern of 
calcific EV release consistent with NTA and TEM analyses.  
 
 
Discussion 
 
 
The present findings provide a novel perspective on EV-mediated vascular fibrocalcific 
response, a crucial determinant of atherosclerotic plaque stability. DDR-1-/- vSMCs exhibited 
a predominantly osteogenic and synthetic phenotype, concomitant with an increase in all 
measured endpoints of SMC-mediated fibrocalcific response both in vitro and in vivo. These 
included calcifying EV release4,5,6 and ALP activity27 as facilitators of mineralization and 
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collagen synthesis as a hallmark of fibrosis, along with enhanced expression of synthetic and 
osteogenic markers. Microcalcifications in collagen-poor areas of the plaque have proven 
detrimental to its structural stability, exerting mechanical stress on surrounding tissue and 
increasing the risk of rupture2,3. We recently demonstrated that collagen acts as a scaffold for 
EV accumulation and formation of macro- or microcalcifications30, however, the cellular 
mechanisms regulating the release of calcifying EVs in response to collagen are unknown. 
The present study introduces DDR-1 as a novel molecular regulator controlling fibrocalcific 
remodeling of the ECM in atherosclerotic plaques through a previously unknown interaction 
with TGF-β pathways, thus associating TGF-β1 with EV release in vSMCs. DDR-1 was found 
to restrict TGF-β1 release and subsequent p38 phosphorylation in vSMCs, thereby limiting 
EV-mediated calcification and collagen matrix production. Furthermore, this study 
complements previous work on a DDR-1-activated negative feedback loop on collagen 
synthesis and remodeling10,13. DDR-1 acts as a sensor for ECM collagen and, in response, 
limits collagen synthesis and calcific EV release by vSMCs, promoting ECM homeostasis. 
Our findings of enhanced fibro-calcification in vitro, increased fibrotic remodeling, ALP 
expression and an abundance of calcific EVs in the DDR-1-/- model in vivo support this 
conclusion. 
An explanation for the differences between the present study and Ahmad et al.15 on SMC-
mediated calcification is given by the use of different calcifying conditions. While Ahmad et al. 
induced calcification in vitro using a high-phosphate medium prone to spontaneous, ALP-
independent mineral formation31, the present study used media supplemented with β-
Glycerophosphate, a specific ALP substrate with low tendency for cell-independent Ca2+ 
complexation32. The differences between currently established in vitro calcification models 
may reflect different pathologies33, the high-phosphate media mimicking the pathogenesis of 
medial calcification in chronic kidney disease34, whereas β-Glycerophosphate may promote 
osteogenic changes by stimulating ALP activity35, a common mechanism of atherogenic 
calcification. Indeed, culturing wild type and DDR-1-/- vSMCs in the high-phosphate media 
used by Ahmad et al. showed a remarkable inversion of the DDR-1-/- phenotype in the 
characteristic end points of fibrocalcific response including EV release (p=0.02, 
Supp.Fig.VIIA), ALP activity (p<0.05, Supp.Fig.VIIB) and TGF-β1 release (p=0.0002, 
Supp.Fig.VIID) but not including TGF-β1 gene expression (Supp.Fig.VIIC). In our in vivo 
model, the abundant presence of accumulating, electron-dense vesicular particles observed 
using DDC-SEM combined with increased expression of ALP in DDR-1-/- LDL-R-/- vasculature 
corroborates the role of DDR-1 in early plaque calcification. Future studies are required to 
elucidate the contribution of stage of plaque maturation as well as varying conditions in the in 
vivo DDR-1-/- model on the differential effects of DDR-1 in fibrocalcific responses observed in 
our two studies. 
The effects of TGF-β1 on atherosclerotic plaque formation are pleiotropic and presumably 
pathway-dependent36. Our study introduces a novel link between DDR-1 and the TGF-β 
pathway in conjunction with the release of calcifying EVs, establishing a potent regulatory 
circuit involving DDR-1 activation, calcified plaque formation and subsequent destabilization. 
Our findings indicate that DDR-1 crosstalk with TGF-β1 signaling is independent of bone 
morphogenetic protein (BMP) and osteogenic regulator Runx237, while influencing the 
expression of Msx2, a Runx2-independent promoter of cytokine-mediated osteogenic 
vascular calcification interacting with the Wnt pathway38 (Supp.Fig.VI). Under calcifying 
conditions, DDR-1-/- vSMCs released increased TGF-β1 in the ECM, concomitant with 
elevated phospho-p38 and suppressed phospho-Smad3 associated with the fibrocalcific 
DDR-1-/- phenotype in vitro and in vivo. These findings complement previous work on the 
positive effect of phospho-p38 on ALP expression and activity39. The reversal of enhanced 
mineral deposition, calcific EV release and ALP activity in DDR-1-/- vSMCs by SB203580 
further suggests a causal relationship between p38 phosphorylation and EV-induced 
fibrocalcific response. We hereby add new evidence to the controversial claims in current 
literature, either confirming12,40 or refuting41 an interaction between DDR-1 and p38 signaling. 
The near-complete suppression of phospho-Smad3 concomitant with enhanced 
mineralization observed in DDR-1-/- models both in vitro and in vivo supports the findings 
obtained by Shimokado et al. using Smad3-/- vSMCs42. TGF-β1 itself is identified as an 
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atherogenic agent, its expression and release related to advanced fibrosis and calcific 
deposition in human atheromata43,22. Moreover, the observed increase in expression and 
release of TGF-β1 by the DDR-1-/- model in vitro and in vivo concurs with a previous study on 
DDR-1 knockdown in a human cancer cell model23. Interestingly, the suppression of p38 
phosphorylation and TGF-β1 release in DDR-1-/- vSMCs by SB431542 suggests a link 
between TGF-β receptor activation and the p38 pathway that has been implicated in aortic 
valve calcification44. In our DDR-1-/- LDL-R-/- mouse model, we observed a strong association 
of TGF-β1-positive areas with PSR-positive fibrotic regions and abundantly present calcific 
EVs forming compact calcifications similar to those found in human atheromata. This 
evidence purports a role of TGF-β pathways crucial to the fibrocalcific DDR-1-/- phenotype 
both in vitro and in vivo. 
Collectively, we conclude that DDR-1 provides a novel connection between vSMC-induced 
fibrosis and EV-mediated calcification in early-stage atherosclerotic plaque formation through 
the adverse regulation of two TGF-β signaling pathways. By restricting TGF-β1 release in 
vSMCs, DDR-1 suppresses phosphorylation of pro-atherogenic p38 and increases phospho-
Smad3, resulting in attenuated fibrosis and calcifying EV release (Fig.6). While further 
studies are required to elucidate the detailed mechanisms of DDR-1 signaling, the novel role 
of DDR-1 in maintaining fibrocalcific homeostasis in vSMCs using the TGF-β pathway 
provides a new perspective on the pathogenesis of plaque formation. DDR-1 hereby exerts a 
TGF-β1-mediated negative feedback on both fibrotic and calcific responses, preventing 
early-onset ECM remodeling in the process of plaque formation. The interaction between 
DDR-1, the TGF-β pathway and the release of calcifying EVs further unveils a range of 
potential implications in congenital and acquired disorders associated with pathological 
vascular calcification. Our findings introduce a heretofore-undisclosed mechanism regulating 
vascular fibrocalcific response and ECM remodeling as major determinants of atherosclerotic 
plaque stability. 
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Significance 
 
 
Vascular fibrosis and calcification determine atherosclerotic plaque stability. 
Microcalcifications formed through the accumulation of calcifying extracellular vesicles (EVs) 
destabilize the plaque and contribute to the risk of plaque rupture. The interaction of collagen 
synthesis and calcifying EV release by vascular smooth muscle cells (vSMCs) driving 
fibrocalcific response in plaque formation is unknown. We identify DDR-1 as a novel 
molecular switch restricting fibrosis and EV-mediated calcification of the extracellular matrix. 
By affecting the release of TGF-β1 and several TGF-β signaling pathways in vSMCs, DDR-1 
provides negative feedback on collagen synthesis, the release of calcifying EVs and the 
expression of alkaline phosphatase, diminishing EV calcifying potential. DDR-1 activation 
thus shuts off excess collagen production and calcific deposition, maintaining homeostasis of 
the extracellular matrix. Our study introduces the DDR-1-TGF-β axis as the missing link 
between fibrosis and EV-mediated calcification in atherosclerotic plaque formation. 
 
 
Figures 
 
 
Fig.1 Nanoparticle Tracking Analysis (NTA) of EVs released from wild type (WT) and DDR-1-
/- vSMCs cultured for 14 and 21 days in normal (NM) and calcifying media supplemented with 
10mM β-Glycerophosphate (β-GP). A, Size distribution of EVs at days 14 and 21 shows a 
characteristic uniform size between 100 and 300nm. B, Concentration of EVs released by 
DDR-1-/- vSMCs is significantly increased compared to WT vSMCs in normal and calcifying 
media at 14 and 21 days of culture. C, TEM imaging of wild type (left) and DDR-1-/- (right) 
vSMCs after 21 days of culture. EVs in the ECM of DDR-1-/- vSMCs (white arrowheads). 
Representative images at 11,000x magnification, bar: 500nm. D, ALP activity assay in 
purified EVs reveals increased calcification potential in EVs released from DDR-1-/- vSMCs. 
Results shown as mean±SD, n=5 for each group, **=p≤0.01, ***=p≤0.001, ****=p≤0.0001. 
 
Fig.2 ALP expression and calcification in wildtype and DDR-1-/- vSMCs. A, Representative 
images of ALP activity staining. B, ALP activity assay in cell lysates shows increased activity 
of cytoplasmic and cell membrane-bound ALP. C, Representative images of Alizarin Red S 
staining in wild type (top) and DDR-1-/- vSMCs (bottom). D, Quantification of mineralization 
measured by Alizarin Red S absorbance at 550nm. Mean±SD, n=5 per group, representative 
results of 3 independent experiments. E, ALP mRNA levels at 14 days of culture relative to 
wild type normal media (WT NM) and normalized to rplp0, n=10 per group. Statistical 
differences labeled as follows: *=p≤0.05, **=p≤0.01, ***=p≤0.001, ****=p≤0.0001. 
 
Fig.3 DDR-1 knockout and TGF-β signaling. A, concentration of TGF-β1 detected by ELISA 
in cell media supernatant after 21 days of culture. B, TGF-β1 mRNA at 14 days of culture 
relative to wild type normal media (WT NM) and normalized to rplp0. Representative results 
of 3 independent experiments in triplicates. C, Western Blot analysis for Smad3 (top panel) 
and p38 (bottom panel) phosphorylation under native conditions (left) and with addition of 
2μmol/L SB431542 (right) after 21 days of culture. D, quantification of Western Blot band 
intensities normalized to GAPDH using NIH ImageJ v1.48. Mean±SD, n=10 per group, 
*=p≤0.05, ***=p≤0.001, ****=p≤0.0001. 
 
Fig.4 SB431542 and SB203580 diminish the osteogenic potential of DDR-1-/- vSMCs. A, 
Alizarin Red S staining after 21 days of culture in native culture media (left), with addition of 
2μmol/L SB431542 (middle) or 10μmol/L SB203580 (right). N=5 per group. B, Alizarin Red S 
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absorbance of the stained wells of A, normalized to wild type vSMCs cultured in native media. 
C, Relative EV concentration, normalized to wild type. D, Relative ALP activity in EVs, 
normalized to wild type. Mean±SD, n=5 per group, **=p≤0.01, ***=p≤0.001, ****=p≤0.0001. 
 
Fig.5 DDR-1 acts as a feedback regulator on vascular fibrocalcific response. A, Fluorescent 
labeling of collagen by CNA probe (green) and microcalcific deposits by osteosense (red) 
produced by wild type (WT) and DDR-1-/- vSMCs in native media (top panel) and with 
addition of 2μmol/L SB431542 (bottom panel) after 21 days of culture. Bar represents 60μm. 
Representative images of 4 independent experiments. B, % positive area for collagen 
(green) and microcalcifications (red). Mean±SD, n=5 per group, **=p≤0.01, ***=p≤0.001. C, 
Top panel: Picrosirius Red staining of LDL-R-/- and DDR-1-/- LDL-R-/- aortic arches under 
polarized microscope at 4x magnification, bar: 200μm. Bottom panel: Immunohistochemical 
staining for TGF-β1 at 2x magnification. Images correspond to Picrosirius Red stained areas 
of B. Bar: 100μm. N=6 for each group. For each n, 2 sections were stained for evaluation. D, 
Quantification of relative frequency of thin, loose and thick, densely packed collagen fibers 
represented by green and orange birefringence using ImageJ v1.48. N=6 per group. E, DDC-
SEM of plaque areas from LDL-R-/- and DDR-1-/- LDL-R-/- aortic arches, with a human 
atheroma for comparison. Mineral is presented in orange and ECM is presented in green. 
Magnification 10,000x, bar: 1μm, n=6 per group. 
 
Fig.6 Ways of DDR-1 interaction with TGF-β signaling through direct suppression of TGF-β1 
(1), phosphorylation of p38 (2) or activation of Smad3 (3), leading to downregulation of 
calcifying EV release and EV-bound ALP by vSMCs. Inverse regulation of Smad3 and p38 
activation through possible downstream interaction (4). 
 
